Patents Assigned to Niiki Pharma, Inc.
  • Medicaments and methods for treating cancer
    Patent number: 9283208
    Abstract: Medicaments and methods for treating cancer are disclosed.
    Type: Grant
    Filed: May 17, 2012
    Date of Patent: March 15, 2016
    Assignee: NIIKI PHARMA INC.
    Inventor: Hooshmand Sheshbaradaran
  • METHOD OF TREATING OSTEOPOROSIS
    Publication number: 20140005159
    Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
    Type: Application
    Filed: August 2, 2013
    Publication date: January 2, 2014
    Applicant: Niiki Pharma , Inc.
    Inventor: Hooshmand Sheshbaradaran
  • METHOD OF TREATING REFRACTORY CANCER
    Publication number: 20130338129
    Abstract: Therapeutic methods for treating refractory cancers are disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: August 23, 2013
    Publication date: December 19, 2013
    Applicant: Niiki Pharma Inc.
    Inventor: Hooshmand Sheshbaradaran
  • METHOD OF TREATING HEMATOLOGICAL CANCERS
    Publication number: 20130253202
    Abstract: Methods and compositions for treating hematological cancer are disclosed, including refractory or resistant hematological cancer.
    Type: Application
    Filed: May 17, 2013
    Publication date: September 26, 2013
    Applicant: Niiki Pharma Inc.
    Inventors: Hooshmand Sheshbaradaran, Rebecca Baerga, Jenel Cobb
  • METHOD OF TREATING NEUROENDOCRINE TUMORS
    Publication number: 20130237510
    Abstract: Methods and compositions for treating neuroendocrine tumors are disclosed.
    Type: Application
    Filed: April 25, 2013
    Publication date: September 12, 2013
    Applicant: Niiki Pharma Inc.
    Inventors: Hooshmand SHESHBARADARAN, William MCCULLOCH
  • METHOD OF TREATING PANCREATIC CANCER
    Publication number: 20130190285
    Abstract: A therapeutic method for treating pancreatic cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: June 11, 2012
    Publication date: July 25, 2013
    Applicant: Niiki Pharma Inc.
    Inventor: Hooshmand SHESHBARADARAN
  • COMBINATION THERAPY USING A RUTHENIUM COMPLEX
    Publication number: 20130129840
    Abstract: A combination therapy is disclosed for treating cancer. The method comprises administering to a cancer patient a therapeutically effective amount of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] or a pharmaceutically acceptable salt thereof, and administering to the patient a therapeutically effective amount of one or more other anti-cancer agents as disclosed herein.
    Type: Application
    Filed: January 18, 2013
    Publication date: May 23, 2013
    Applicant: Niiki Pharma Inc.
    Inventor: Niiki Pharma Inc.
  • METHOD OF TREATING REFRACTORY CANCER
    Publication number: 20130131031
    Abstract: Therapeutic methods for treating refractory cancers are disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: January 17, 2013
    Publication date: May 23, 2013
    Applicant: NIIKI PHARMA INC.
    Inventor: NIIKI PHARMA INC.
  • METHOD FOR TREATING ESOPHAGEAL CANCER
    Publication number: 20130116226
    Abstract: Methods and compositions for treating gastric and esophageal cancers are disclosed.
    Type: Application
    Filed: October 29, 2012
    Publication date: May 9, 2013
    Applicant: Niiki Pharma Inc.
    Inventor: Niiki Pharma Inc.
  • METHOD FOR TREATING HEMATOLOGICAL CANCERS
    Publication number: 20130116225
    Abstract: Methods and compositions for treating hematological cancer are disclosed, including refractory or resistant hematological cancer.
    Type: Application
    Filed: August 13, 2012
    Publication date: May 9, 2013
    Applicant: NIIKI PHARMA INC.
    Inventors: Hooshmand SHESHBARADARAN, Aram PROKOP, Rebecca Baerga, Jenel Cobb, Mojtaba Seied Valiahdi, Soo-Young LEE, Bernhard KEPPLER
  • COMBINATION THERAPY WITH A PROTEASOME INHIBITOR AND A GALLIUM COMPLEX
    Publication number: 20130096068
    Abstract: A combination therapy is disclosed for treating cancer. The method comprises identifying a patient diagnosed of cancer and in need of treatment, administering to a cancer patient a therapeutically effective amount of a compound of Formula (I), and administering to said patient a therapeutically effective amount of a proteasome inhibitor.
    Type: Application
    Filed: October 19, 2012
    Publication date: April 18, 2013
    Applicant: Niiki Pharma Inc.
    Inventor: Niiki Pharma Inc.
  • METHOD OF TREATING BRAIN CANCER
    Publication number: 20130096099
    Abstract: A therapeutic method for treating brain cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: October 29, 2012
    Publication date: April 18, 2013
    Applicant: NIIKI PHARMA INC.
    Inventor: Niiki Pharma Inc.
  • METHOD FOR TREATING BRAIN CANCER
    Publication number: 20130090321
    Abstract: Methods and compositions for treating brain cancer are disclose including refractory brain cancer.
    Type: Application
    Filed: August 27, 2012
    Publication date: April 11, 2013
    Applicant: NIIKI PHARMA INC.
    Inventors: Hooshmand SHESHBARADARAN, Rebecca BAERGA, Jenel COBB, Mojtaba Seied VALIAHDI, Bernhard KEPPLER
  • METHOD OF TREATING PROSTATE CANCER
    Publication number: 20130090320
    Abstract: A therapeutic method for treating prostate cancer is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: October 23, 2012
    Publication date: April 11, 2013
    Applicant: NIIKI PHARMA INC.
    Inventor: NIIKI PHARMA INC.
  • METHOD OF TREATING PANCREATIC CANCER
    Publication number: 20130090322
    Abstract: A therapeutic method for treating pancreatic cancer is disclosed comprising administering to a patient in need of treatment a gallium complex according to Formula (I) provided herein.
    Type: Application
    Filed: October 23, 2012
    Publication date: April 11, 2013
    Applicant: NIIKI PHARMA INC.
    Inventor: NIIKI PHARMA INC.
  • Method of manufacturing a ruthenium complex
    Patent number: 8362266
    Abstract: A method of making an alkali metal salt of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] is disclosed.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: January 29, 2013
    Assignee: Niiki Pharma Inc.
    Inventor: Berhhard Keppler
  • METHOD OF TREATING HEPATOCELLULAR CARCINOMA
    Publication number: 20120115833
    Abstract: A therapeutic method for treating hepatocellular carcinoma is disclosed comprising administering to a patient in need of treatment a ruthenium complex salt.
    Type: Application
    Filed: October 17, 2011
    Publication date: May 10, 2012
    Applicant: NIIKI PHARMA INC.
    Inventors: Walter Berger, Petra Heffeter, Bernhard Keppler, Hooshmand Sheshbaradaran
  • Method of treating osteoporosis
    Publication number: 20120022036
    Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
    Type: Application
    Filed: September 30, 2011
    Publication date: January 26, 2012
    Applicant: NIIKI PHARMA INC.
    Inventor: Hooshmand SHESHBARADARAN
  • Use of gallium(III) complexes for the treatment of melanomas
    Patent number: 7919486
    Abstract: The invention relates to the use of gallium (III) complexes for the treatment of melanomas.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: April 5, 2011
    Assignee: Niiki Pharma Inc.
    Inventor: Bernhard Keppler
  • Anticancer compositions, and methods of making and using the same
    Patent number: 7589084
    Abstract: The invention relates to a composition (A), obtained by reacting a compound of the general formula (I) M3-n-p-2pr[RuX6-n-p-q-2rBn(H2O)p(OH)q(O)r]2r+1??(I) with a compound of the general formula (II) B?(HX?)S??(II).
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: September 15, 2009
    Assignee: Niiki Pharma, Inc.
    Inventor: Bernhard Keppler